Genetic analysis of immunomodulating factors in sporadic Parkinson's disease

Immunomodulating factors have been shown to play a role in the pathogenesis of Parkinson's disease (PD) by biochemical methods. In order to investigate functionally important genes of the tumor necrosis factor alpha (TNF alpha) pathway we studied the frequency of DNA polymorphisms in the interleukin 6 (IL6), the TNF alpha, and the TNF alpha receptor 1 (TNFR1) genes in 264 sporadic German PD patients and in 183 age and sex matched German healthy controls. Analyzing the TNF alpha-308 polymorphism we found heterozygous individuals carrying alleles 1 and 2 more frequently in patients with a relative risk of 1.56 (p = 0.046, p(c) = 0.13, chi(2) = 3.98). In contrast, the frequency of the B/2 haplotype described by the TNFR1 - 609 and TNFRI + 36 polymorphisms was significantly decreased in our PD patients group (p = 0.0097, p(c) = 0.048, chi(2) = 6.69) with a relative risk reduced to 0.52. Our results suggest an involvement of immunomodulating factors in the pathogenesis of sporadic PD as revealed by a molecular genetic approach.